hfa 23: apollo-b: patisiran treatment for cardiac amyloidosis
Published 1 year ago • 501 plays • Length 3:12Download video MP4
Download video MP3
Similar videos
-
2:05
patisiran for transthyretin cardiac amyloidosis | nejm
-
2:46
hfa 23: monitor-hf: improving qol& reducing hf hospitalisations with pap monitoring
-
6:20
acc 23 expert consensus decision pathway on cardiac amyloidosis: highlights
-
4:43
hf 2022: helios-a: phase 3 study of vutrisiran in patients with hattr amyloidosis | dr garcia-pavia
-
2:11
onpattro (patisiran) for treatment of polyneuropathy caused by hereditary attr amyloidosis
-
9:43
new treatment for hattr amyloidosis
-
1:31:25
cardiac amyloidosis – 2024 rare cardiac conditions conference
-
8:42
ash 22 | al amyloidosis highlights
-
6:17
treating hattr amyloidosis: historical overview
-
0:59
sphere persistent af trial
-
4:42
cardiac amyloidosis: evaluating patients with suspected cardiac amyloidosis
-
7:12
hfsa 24: myosin inhibition in hfpef: primary results from embark hfpef
-
49:35
phenotyping hfpef: the case for cardiac amyloidosis
-
17:37
patisiran, an rnai therapeutic, for hereditary transthyretin amyloidosis
-
3:32
acc 22: apollo fih study to investigate sirna in raised lipoprotein(a) | dr steven e nissen
-
6:41
viva 23: promise ii: 12m results from pivotal trial of limflow system
-
0:57
the promise of car-t therapy for the treatment of al amyloidosis
-
2:45
burning questions: asct in al amyloidosis